Volatile anesthetic isoflurane inhibits LTP induction of hippocampal CA1 neurons through α4β2 nAChR subtype-mediated mechanisms

Annales Francaises d'Anesthesie et de Reanimation

Volumn 32, Issue 10, 2013, Pages

  Piao, M H ^a,b   Liu, Y ^b   Wang, Y S ^a   Qiu, J P ^a   Feng, C S ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Anesthesia; Cognitive function; Hippocampus; Long term potentiation; Nicotine; Receptors

Indexed keywords

3 (2 AZETIDINYLMETHOXY)PYRIDINE; DIHYDRO BETA ERYTHROIDINE; EPIBATIDINE; ISOFLURANE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR ALPHA4BETA2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN REGION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; HIPPOCAMPAL CA1 REGION; LONG TERM POTENTIATION; MALE; NERVE CELL; NONHUMAN; RAT; RECEPTOR BLOCKING; SYNAPTIC INHIBITION;

ANESTHESIA; ANESTHÉSIE; COGNITIVE FUNCTION; FONCTION COGNITIVE; HIPPOCAMPE; HIPPOCAMPUS; LONG-TERM POTENTIATION; NICOTINE; POTENTIALISATION À LONG TERME; RECEPTORS; RÉCEPTEURS;

ANESTHETICS, INHALATION; ANIMALS; AZETIDINES; BICYCLO COMPOUNDS, HETEROCYCLIC; CA1 REGION, HIPPOCAMPAL; DIHYDRO-BETA-ERYTHROIDINE; DRUG INTERACTIONS; ELECTRIC STIMULATION; ISOFLURANE; LONG-TERM POTENTIATION; MECAMYLAMINE; MUSCARINIC AGONISTS; NEURAL PATHWAYS; NEURONS; NICOTINE; NICOTINIC AGONISTS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

EID: 84886581459     PISSN: 07507658     EISSN: 17696623     Source Type: Journal    
DOI: 10.1016/j.annfar.2013.05.012     Document Type: Article

References (47)

1. Lin D., Zuo Z. Isoflurnae induces hippocampal cell injury and cognitive impairments in adult rats. Neuropharmacology 2011, 61:1354-1359.
2. Culley D.J., Baxter M., Yukhananov R., Crosby G. The memory effects of general anesthesia persist for weeks in young and aged rats. Anesth Analg 2003, 96:1004-1009.
3. Culley D.J., Baxter M.G., Crosby C.A., Yukhananov R., Crosby G. Impaired acquisition of spatial memory 2 weeks after isoflurane and isoflurane nitrous oxide anesthesia in aged rats. Anesth Analg 2004, 99:1993-1997.
4. Wanda Simon Gerhard Hapfelmeier Eberhard Kochs Zieglgänsberger W., Rammes G. Isoflurane blocks synaptic plasticity in the mouse hippocampus. Anesthesiology 2001, 94:1058-1065.
5. Dai S., Perouansky M., Pearce R.A. Isoflurane enhances both fast and slow synaptic inhibition in the hippocampus at amnestic concentrations. Anesthesiology 2012, 116:816-823.
6. Rada E.M., Tharakan E.C., Flood P. Volatile anesthetics reduce agonist affinity at nicotinic acetylcholine receptors in the brain. Anesth Analg 2003, 96:108-111.
7. Matsuura T., Kamiya Y., Itoh H., Higashi T., Yamada Y., Andoh T. Inhibitory effects of isoflurane and nonimmobilizing halogenated compounds on neuronal nicotinic acetylcholine receptors. Anesthesiology 2002, 97:1541-1549.
8. Mawhinney L.J., de Rivero Vaccari J.P., Alonso O.F., Jimenez C.A., Furones C., Moreno W.J., et al. Isoflurane/nitrous oxide anesthesia induces increases in NMDA receptor subunit NR2B protein expression in the aged rat brain. Brain Res 2012, 11(1431):23-34.
9. Dickinson R., Peterson B.K., Banks P., Simillis C., Martin J.C., Valenzuela C.A., et al. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor by the anesthetics xenon and isoflurane: evidence from molecular modeling and electrophysiology. Anesthesiology 2007, 107:756-767.
10. Hirota K., Roth S.H., Fujimura J., Masuda A., Ito Y. GABAergic mechanisms in the action of general anesthetics. Toxicol Lett 1998, 23:100-101. [203-7].
11. Sasaki R., Hirota K., Roth S.H., Yamazaki M. Extracellular magnesium ion modifies the actions of volatile anesthetics in area CA1 of rat hippocampus in vitro. Anesthesiology 2002, 96:681-687.
12. Minami K., Wick M.J., Stern-Bach Y., Dildy-Mayfield J.E., Brozowski S.J., Gonzales E.L., et al. Sites of volatile anesthetic action on kainate (glutamate receptor 6) receptors. J Biol Chem 1998, 273:8248-8255.
13. Yamakura T., Bertaccini E., Trudell J.R., Harris R.A. Anesthetics and ion channels: Molecular models and sites of action. Annu Rev Pharmacol Toxicol 2001, 41:23-51.
14. Campagna J.A., Miller K.W., Forman S.A. Mechanisms of actions of inhaled anesthetics. N Engl J Med 2003, 348:2110-2124.
15. Rudolph U., Antkowiak B. Molecular and neuronal substrates for general anaesthetics. Nat Rev Neurosci 2004, 5:709-720.
16. Gotti C., Fornasari D., Clementi F. Human neuronal nicotinic receptors. Prog Neurobiol 1997, 53:199-237. [Review].
17. Satoshi Fujii Zhanxin Ji Naonori Morita Sumikawa K. Acute and chronic nicotine exposure differentially facilitate the induction of LTP. Brain Res 1999, 30(846):137-143.
18. Parameshwaran K., Buabeid M.A., Karuppagounder S.S., Uthayathas S., Thiruchelvam K., Shonesy B., et al. Developmental nicotine exposure induced alterations in behavior and glutamate receptor function in hippocampus. Cell Mol Life Sci 2012, 69:829-841.
19. Ishizeki J., Nishikawa K., Kubo K., Saito S., Goto F. Amnestic concentrations of sevoflurane inhibit synaptic plasticity of hippocampal CA1 neurons through Gamma-aminobutyric acid-mediated mechanisms. Anesthesiology 2008, 108:447-456.
20. Cui T., Mowrey D., Bondarenko V., Tillman T., Ma D., Landrum E., et al. NMR structure and dynamics of a designed water-soluble transmembrane domain of nicotinic acetylcholine receptor. Biochim Biophys Acta 2012, 1818:617-626.
21. Mori T., Zhao X., Zuo Y., Aistrup G.L., Nishikawa K., Marszalec W., et al. Modulation of neuronal nicotinic acetylcholine receptors by halothane in rat cortical neurons. Mol Pharmacol 2001, 59:732-743.
22. Yamashita M., Mori T., Nagata K., Yeh J.Z., Narahashi T. Isoflurane modulation of neuronal nicotinic acetylcholine receptors expressed in human embryonic kidney cells. Anesthesiology 2005, 102:76-84.
23. Flood P., Ramirez-Latorre J., Role L. Alpha 4 beta 2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but alpha 7-type nicotinic acetylcholine receptors are unaffected. Anesthesiology 1997, 86:859-865.
24. Namgung U., Valcourt E., Routtenberg A. Long-term potentiation in vivo in the intact mouse hippocampus. Brain Res 1995, 689(1):85-92.
25. Scheller M., Bufler J., Schneck H., Kochs E., Franke C. Isoflurane and sevoflurane interact with the nicotinic acetylcholine receptor channels in micromolar concentrations. Anesthesiology 1997, 86:118-127.
26. Firestone L.L., Sauter J.F., Braswell L.M., Miller K.W. Actions of general anesthetics on acetylcholine receptor-rich membranes from Torpedo californica. Anesthesiology 1986, 64:694-702.
27. Franks N.P., Lieb W.R. Temperature dependence of the potency of volatile general anesthetics: Implications for in vitro experiments. Anesthesiology 1996, 84:716-720.
28. Justin W., Thomas J. Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Mol Neurobiol 2008, 38:101-121.
29. Morris R.G., Anderson E., Lynch G.S., Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 1986, 319:774-776.
30. Arai A., Guidotti A., Costa E., Lynch G. Effect of the AMPA receptor modulator IDRA 21 on LTP in hippocampal slices. Neuroreport 1996, 7:2211-2215.
31. Stäubli U., Perez Y., Xu F.B., Rogers G., Ingvar M., Stone-Elander S., et al. Centrally active modulators of glutamate receptors facilitate the induction of long-term potentiation in vivo. Proc Natl Acad Sci U S A 1994, 91:11158-11162.
32. Simon W., Hapfelmeier G., Kochs E., Zieglgänsberger W., Rammes G. Isoflurane blocks synaptic plasticity in the mouse hippocampus. Anesthesiology 2001, 94:1058-1065.
33. Haseneder R., Kratzer S., von Meyer L., Eder M., Kochs E., Rammes G. Isoflurane and sevoflurane dose-dependently impair hippocampal long-term potentiation. Eur J Pharmacol 2009, 623:47-51.
34. Tassonyi E., Charpantier E., Muller D., Dumont L., Bertrand D. The role of nicotinic acetylcholine receptors in the mechanisms of anesthesia. Brain Res Bull 2002, 57:133-150.
35. Lloyd G.K., Williams M. Neuronal nicotinic acetylcholine receptors as novel drug targets. J Pharmacol Exp Ther 2000, 292:461-467.
36. Cordero-Erausquin M., Marubio L.M., Klink R., Changeux J.P. Nicotinic receptor function: new perspectives from knockout mice. Trends Pharmacol Sci 2000, 21:211-217.
37. Grasshoff C., Drexler B., Antkowiak B. Effects of cholinergic overstimulation on isoflurane potency and efficacy in cortical and spinal networks. Toxicology 2007, 229:206-213.
38. Ye L., Qi J.S., Qiao J.T. Long-term potentiation in hippocampus of rats is enhanced by endogenous acetylcholine in a way that is independent of N-methyl-d-aspartate receptors. Neurosci Lett 2001, 300:145-148.
39. 1 neurons of rat hippocampal slices. J Pharmacol Exp Ther 1997, 283:1396-1411.
40. Jones S., Yakel J.L. Functional nicotinic ACh receptors on interneurons in the rat hippocampus. J Physiol 1997, 504:603-610.
41. Ji D., Dani J.A. Inhibition and disinhibition of pyramidal neurons by activation of nicotinic receptors on hippocampal interneurons. J Neurophysiol 2000, 83:2682-2690.
42. Kawai H., Zago W., Berg D.K. Nicotinic alpha 7 receptor clusters on hippocampal GABAergic neurons: regulation by synaptic activity and neurotrophins. J Neurosci 2002, 22:7903-7912.
43. Yamazaki Y., Jia Y., Hamaue N., Sumikawa K. Nicotine-induced switch in the nicotinic cholinergic mechanisms of facilitation of long-term potentiation induction. Eur J Neurosci 2005, 22:845-860.
44. Mansvelder H.D., McGehee D.S. Cellular and synaptic mechanisms of nicotine addiction. J Neurobiol 2002, 53:606-617.
45. Zhang J., Berg D.K. Reversible inhibition of GABAA receptors by alpha7-containing nicotinic receptors on the vertebrate postsynaptic neurons. J Physiol 2007, 579:753-763.
46. Cui T., Canlas C.G., Xu Y., Tang P. Anesthetic effects on the structure and dynamics of the second transmembrane domains of nAChR alpha4beta2. Biochim Biophys Acta 2010, 1798:161-166.
47. Wang X. Nicotinic receptors partly mediate brainstem autonomic dysfunction evoked by the inhaled anesthetic isoflurane. Anesth Analg 2009, 108:134-141.